Cardiovascular Disease Doctors in Hinsdale, IL Accepting Medicare

25 Cardiovascular Disease doctors found. Showing 21 - 25

Duane F Follman, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 11 Salt Creek Ln, Hinsdale, IL 60521 Phone: 630-789-3422    Fax: 630-789-9093

Dr. Meechai Tessalee, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 11 Salt Creek Ln, Hinsdale, IL 60521 Phone: 630-789-3422    Fax: 630-789-9093

Daniel E Krauss, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 11 Salt Creek Ln, Hinsdale, IL 60521 Phone: 630-789-3422    Fax: 630-789-9093

Dr. Robert Coe Finley Iii, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 908 N Elm St Ste 404, Hinsdale, IL 60521 Phone: 630-789-3422

Dr. Saurabh Shah, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 908 N Elm St Ste 404, Hinsdale, IL 60521 Phone: 630-789-3422

News Archive

Molecule responsible for neuronal branches identifed

The human brain consists of about 100 billion (1011) neurons, which altogether form about 100 trillion (1014) synaptic connections with each other. A crucial mechanism for the generation of this complex wiring pattern is the formation of neuronal branches. The neurobiologists Dr. Hannes Schmidt and Professor Fritz G. Rathjen at the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have now discovered a molecule that regulates this vital process. At the same time they have succeeded in elucidating the signaling cascade induced by this molecule (PNAS, Early Edition, 2009, doi:10.1073).

Study examines UK's NICE as model producer of HTA

GfK HealthCare, one the largest providers of fully integrated custom health care marketing research in the world, announced today the undertaking of a first-ever research study aimed at examining the UK's National Institute for Health and Clinical Excellence as a model producer of Health Technology Appraisals, and its impact on decision making in ex-UK health care systems.

FDA approves 45mm GORE TAG Thoracic Endoprosthesis device

W. L. Gore & Associates (Gore) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market a 45 mm diameter version of the GORE® TAG® Thoracic Endoprosthesis for treatment of aneurysms of the descending thoracic aorta. The larger diameter device allows treatment of TAAs with proximal and distal neck diameters ranging from 37 - 42 mm and is now available for commercial use in the U.S.

Idenix Pharmaceuticals prices underwritten offering of common stock at $4.35 per share

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the pricing of an underwritten offering of 6,460,672 shares of its common stock at a price of $4.35 per share. After the underwriting discount and estimated offering expenses payable by the company, the company expects to receive net proceeds of approximately $26.2 million. All of the shares are being sold by Idenix.

Alcohol related cancer risks underplayed by industry says new research

A report out of the UK reveals that just like the tobacco industry tried for decades to suppress the harmful effects of tobacco and cigarette smoking, the alcohol industry too is trying to underplay the actual cancer risks associated with alcohol intake. The new research is published in the journal Drug and Alcohol Review.

Read more Medical News

› Verified 4 days ago

• 1
• 2(current)